Clinipace buys regulatory affairs unit
Clinipace Worldwide has bought Regulus Pharmaceutical Consulting to add regulatory expertise to its eClinical contract research services business.
Clinipace Worldwide has bought Regulus Pharmaceutical Consulting to add regulatory expertise to its eClinical contract research services business.
Clondalkin is to buy the printed components unit from Catalent as part of an ongoing acquisition strategy in the strong sector growth.